Hesperidin acts as an anti-cancer agent by promoting apoptosis in malignant cells such as liver cancer and bladder cancer cells via NF-κB, MAPK, and PI3K/AKT pathways. The gene discussed is AKT1; the disease is urinary bladder carcinoma.